Design of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS)
- PMID: 24029743
- PMCID: PMC3954445
- DOI: 10.1136/thoraxjnl-2013-203897
Design of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS)
Abstract
Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS) is a multicentre observational study of chronic obstructive pulmonary disease (COPD) designed to guide future development of therapies for COPD by providing robust criteria for subclassifying COPD participants into groups most likely to benefit from a given therapy during a clinical trial, and identifying biomarkers/phenotypes that can be used as intermediate outcomes to reliably predict clinical benefit during therapeutic trials. The goal is to enrol 3200 participants in four strata. Participants undergo a baseline visit and three annual follow-up examinations, with quarterly telephone calls. Adjudication of exacerbations and mortality will be undertaken.
Keywords: COPD Exacerbations; COPD epidemiology; Emphysema; Imaging/CT MRI etc.
References
-
- Minino A, Xu J, Kochanek M. Deaths: Preliminary Data for 2008. National Vital Statistics Report. 2010;59:1–71. - PubMed
-
- Global Strategy for Diagnosis, Management and Prevention of COPD (Updated 2013) 2013 http://www.goldcopd.org/uploads/users/files/GOLD_Report_2013_Feb20.pdf.
-
- Vestbo J, Rennard S. Chronic obstructive pulmonary disease biomarker(s) for disease activity needed--urgently. Am J Respir Crit Care Med. 182(7):863–4. - PubMed
-
- Vestbo J, Anderson W, Coxson HO, et al. Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Eur Respir J. 2008;31:869–73. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- HHSN268200900019C/HL/NHLBI NIH HHS/United States
- HHSN268200900009C/WH/WHI NIH HHS/United States
- R01HL110906/HL/NHLBI NIH HHS/United States
- HHSN268200900015C/HL/NHLBI NIH HHS/United States
- HHSN268200900018C/HL/NHLBI NIH HHS/United States
- HHSN268200900014C/HL/NHLBI NIH HHS/United States
- R01 HL112986/HL/NHLBI NIH HHS/United States
- P30 ES005605/ES/NIEHS NIH HHS/United States
- HHSN268200900016C/HL/NHLBI NIH HHS/United States
- R01 HL110906/HL/NHLBI NIH HHS/United States
- HHSN268200900017C/HL/NHLBI NIH HHS/United States
- HHSN268200900020C/HL/NHLBI NIH HHS/United States
- HHSN268200900013C/HL/NHLBI NIH HHS/United States
- HHSN2682009000019C/PHS HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases